Open Menu Close Menu Open Search Close Search


Recombinant and synthetic nucleic acid research must be done in accordance with the current edition of the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. Infectious Agent research must be done following the guidelines issued in the NIH/CDC publication Biosafety in Microbiological and Biomedical Laboratories. Significant issues of non-compliance are reportable to the Office of Science Policy at the National Institutes of Health and to the relevant funding agency.

Whistleblower Policy

The Institutional Biosafety Committees (IBC) has provided the following methods that may be used to report any deficiency or non-compliance with the use of biohazardous materials at this Institution:

  1. Call, write, e-mail, or speak to:
  • The Grafton IBC Chair: Dr. Sawkat Anwer at (508) 839-8788
  • The Boston/Medford IBC Chair: Dr. Cheleste Thorpe at (617) 636-0245
  • The Biosafety Manager: Dr. Melanie Marketon at (617) 636-0969
  • The IACUC/IBC Regulatory Director: Valerie Parkison at (617) 636-6599
  • The Institutional Officials: Heather Gipson-Cosier, JD (Tufts University) at (617) 636-0398 or Susan Blanchard (Tufts Medical Center) at (617) 636-5480
  1. If you would like to remain anonymous, you may leave a message on the University’s 24-hour hotline (617) 636-2492, which is specifically designated for reporting research misconduct. It is managed by the Office of the Vice Provost for Research. Alternatively, concerns can be registered through EthicsPoint through their website or by calling (866) 384-4277. Indicate “Tufts University” as the organization. Anonymous reports will be handled in the same fashion as other reports.

Reported issues will be investigated and solutions determined on a case-by-case basis. Verification will be provided to the complainant (if known) that the report has been received and the issue is under investigation. After a report is received, if it is determined to be an issue of non-compliance, the resolution will be reported in the IBC’s Minutes.